Zhu Rongping, Li Ju, Lian Siyan, Li Yishan, Cai Meili, Cao Yingping, Xu Xiaohong
Department of Laboratory Medicine, Fujian Medical University Union Hospital, Fuzhou, Fujian, 350001, People's Republic of China.
Department of Blood Transfusion, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian, 350001, People's Republic of China.
Infect Drug Resist. 2025 Jan 6;18:83-92. doi: 10.2147/IDR.S494208. eCollection 2025.
Therefore, the objectives of this study were to investigate the prevalence of carbapenem-resistant hypervirulent (CR-hvKp) in Fujian Medical University Union Hospital, identify their genetic characters, characterize their resistance profiles, and identify risk factors for their infection to improve prevention and treatment strategies for CR-hvKp in the area.
Between January 2021 and January 2022, clinically identified carbapenem-resistant (CRKp) isolates were collected. A PCR assay was used to detect the K capsule type, virulence genes, carbapenemase genes, and membrane pore protein. ERIC-PCR was carried out for homology analysis. Antimicrobial susceptibility test was used to determine drug resistance. Logistic multivariate regression analysis was conducted to confirm the risk factors for CR-hvKp infection.
In total, 239 CRKp isolates were obtained. The virulence genes with the highest detection rates were , and . Of these isolates, 54 (22.59%) carried both and , thus classifying them as CR-hvKp. All CR-hvKp isolates carried . Furthermore, capsular serotypes K64 (94.44%) and K47 (3.70%) were detected. Resistance was observed against most common antibiotics, with the exception of complete sensitivity to ceftazidime-avibactam. ERIC-PCR indicated a potential clonal spread among CR-hvKp. Multivariate analysis found that changing beds was a risk factor for CR-hvKp infection.
Currently, the hospital predominantly carries K64 CR-hvKp that harbors the . Our study found that changing patient beds was an independent risk factor for CR-hvKp infection.
因此,本研究的目的是调查福建医科大学附属协和医院耐碳青霉烯类高毒力肺炎克雷伯菌(CR-hvKp)的流行情况,鉴定其基因特征,描述其耐药谱,并确定其感染的危险因素,以改进该地区CR-hvKp的预防和治疗策略。
收集2021年1月至2022年1月临床鉴定的耐碳青霉烯类肺炎克雷伯菌(CRKp)分离株。采用聚合酶链反应(PCR)检测K荚膜类型、毒力基因、碳青霉烯酶基因和膜孔蛋白。进行肠杆菌基因间重复序列PCR(ERIC-PCR)同源性分析。采用药敏试验确定耐药性。进行多因素logistic回归分析以确定CR-hvKp感染的危险因素。
共获得239株CRKp分离株。检测率最高的毒力基因是[此处原文缺失具体基因名称]。在这些分离株中,54株(22.59%)同时携带[此处原文缺失具体基因名称],因此将它们归类为CR-hvKp。所有CR-hvKp分离株均携带[此处原文缺失具体基因名称]。此外,检测到荚膜血清型K64(94.44%)和K47(3.70%)。除对头孢他啶-阿维巴坦完全敏感外,对大多数常用抗生素均观察到耐药。ERIC-PCR表明CR-hvKp之间可能存在克隆传播。多因素分析发现,更换床位是CR-hvKp感染的危险因素。
目前,该医院主要携带携带[此处原文缺失具体基因名称]的K64型CR-hvKp。我们的研究发现,更换患者床位是CR-hvKp感染的独立危险因素。